Jaguar Animal Health Inc Market Cap ($786.58K)
Market Cap & Net Worth: Jaguar Animal Health Inc (JAGX)
Jaguar Animal Health Inc market cap. Jaguar Animal Health Inc (NASDAQ:JAGX) has a market capitalization of $786.58K ($786.58K) as of November 9, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30811 globally and #6265 in its home market, demonstrating a -80.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jaguar Animal Health Inc's stock price $0.40 by its total outstanding shares 1945542 (1.95 Million). Also see how efficiently does Jaguar Animal Health Inc generate cash for how efficiently the company converts equity into cash flow.
Jaguar Animal Health Inc Market Cap History (2015–2026)
Jaguar Animal Health Inc market cap history from 2015 to 2026. Data shows change from $1.95 Trillion to $786.58K (-73.59% CAGR). Check Jaguar Animal Health Inc (JAGX) stock price for real-time trading data and today's change.
Index Memberships
Jaguar Animal Health Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.59 Trillion | 0.00% | #903 of 976 |
|
NASDAQ Composite
IXIC
|
$39.00 Trillion | 0.00% | #2858 of 3165 |
Weight: Jaguar Animal Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jaguar Animal Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jaguar Animal Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jaguar Animal Health Inc (JAGX) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.16x
Jaguar Animal Health Inc's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.95 Trillion | $141.52K | -$14.73 Million | 13747178.90x | N/A |
| 2017 | $1.95 Trillion | $4.36 Million | -$21.97 Million | 446103.88x | N/A |
| 2018 | $421.03 Billion | $4.42 Million | -$32.15 Million | 95337.68x | N/A |
| 2019 | $21.04 Billion | $5.78 Million | -$38.54 Million | 3642.96x | N/A |
| 2020 | $21.41 Billion | $9.38 Million | -$33.81 Million | 2280.86x | N/A |
| 2021 | $9.11 Billion | $4.33 Million | -$52.59 Million | 2100.38x | N/A |
| 2022 | $761.68 Million | $11.96 Million | -$47.45 Million | 63.71x | N/A |
| 2023 | $17.63 Million | $9.76 Million | -$41.30 Million | 1.81x | N/A |
| 2024 | $1.96 Million | $11.69 Million | -$38.49 Million | 0.17x | N/A |
| 2025 | $1.81 Million | $11.51 Million | -$53.43 Million | 0.16x | N/A |
Competitor Companies of JAGX by Market Capitalization
Companies near Jaguar Animal Health Inc in the global market cap rankings as of November 9, 2026. Also see Jaguar Animal Health Inc total assets for a full breakdown of the balance sheet.
Key companies related to Jaguar Animal Health Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Jaguar Animal Health Inc (2015–2026)
Market capitalization of Jaguar Animal Health Inc from 2015 to today. Between 2015 and today, Jaguar Animal Health Inc's market cap moved from $1.95 Trillion to $ 786.58K, with a yearly change of -73.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $786.58K | -56.58% |
| 2025 | $1.81 Million | -7.80% |
| 2024 | $1.96 Million | -88.85% |
| 2023 | $17.63 Million | -97.69% |
| 2022 | $761.68 Million | -91.63% |
| 2021 | $9.11 Billion | -57.46% |
| 2020 | $21.41 Billion | +1.75% |
| 2019 | $21.04 Billion | -95.00% |
| 2018 | $421.03 Billion | -78.36% |
| 2017 | $1.95 Trillion | 0.00% |
| 2016 | $1.95 Trillion | 0.00% |
| 2015 | $1.95 Trillion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Jaguar Animal Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $786.58K USD |
| MoneyControl | $786.58K USD |
| MarketWatch | $786.58K USD |
| marketcap.company | $786.58K USD |
| Reuters | $786.58K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more